| Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer JN Graff, JJ Alumkal, CG Drake, GV Thomas, WL Redmond, M Farhad, ... Oncotarget 7 (33), 52810, 2016 | 391 | 2016 |
| Inhibition of cancer cell invasion and metastasis by genistein JM Pavese, RL Farmer, RC Bergan Cancer and Metastasis Reviews 29, 465-482, 2010 | 326 | 2010 |
| Circulating giant macrophages as a potential biomarker of solid tumors DL Adams, SS Martin, RK Alpaugh, M Charpentier, S Tsai, RC Bergan, ... Proceedings of the National Academy of Sciences 111 (9), 3514-3519, 2014 | 321 | 2014 |
| MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer L Xu, S Chen, RC Bergan Oncogene 25 (21), 2987-2998, 2006 | 271 | 2006 |
| Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells X Huang, S Chen, L Xu, Y Liu, DK Deb, LC Platanias, RC Bergan Cancer research 65 (8), 3470-3478, 2005 | 271 | 2005 |
| Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity E Kyle, L Neckers, C Takimoto, G Curt, R Bergan Molecular Pharmacology 51 (2), 193-200, 1997 | 255 | 1997 |
| Dietary genistein inhibits metastasis of human prostate cancer in mice M Lakshman, L Xu, V Ananthanarayanan, J Cooper, CH Takimoto, ... Cancer research 68 (6), 2024-2032, 2008 | 225 | 2008 |
| Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer CH Takimoto, K Glover, X Huang, SA Hayes, L Gallot, M Quinn, ... Cancer Epidemiology Biomarkers & Prevention 12 (11), 1213-1221, 2003 | 198 | 2003 |
| Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial SA Khan, RT Chatterton, N Michel, M Bryk, O Lee, D Ivancic, R Heinz, ... Cancer prevention research 5 (2), 309-319, 2012 | 195 | 2012 |
| A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer A Thibault, WD Figg, RC Bergan, RM Lush, CE Myers, A Tompkins, ... Tumori Journal 84 (1), 87-89, 1998 | 171 | 1998 |
| Androgen receptor-independent function of FoxA1 in prostate cancer metastasis HJ Jin, JC Zhao, I Ogden, RC Bergan, J Yu Cancer research 73 (12), 3725-3736, 2013 | 157 | 2013 |
| Pharmacokinetics of thalidomide in an elderly prostate cancer population WD Figg, S Raje, KS Bauer, A Tompkins, D Venzon, R Bergan, A Chen, ... Journal of pharmaceutical sciences 88 (1), 121-125, 1999 | 152 | 1999 |
| Labeling TiO2 Nanoparticles with Dyes for Optical Fluorescence Microscopy and Determination of TiO2–DNA Nanoconjugate Stability KT Thurn, T Paunesku, A Wu, EMB Brown, B Lai, S Vogt, J Maser, ... Small 5 (11), 1318-1325, 2009 | 147 | 2009 |
| Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy R Bergan, Y Connell, B Fahmy, L Neckers Nucleic acids research 21 (15), 3567-3573, 1993 | 146 | 1993 |
| Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization G Thrivikraman, A Athirasala, R Gordon, L Zhang, R Bergan, DR Keene, ... Nature communications 10 (1), 3520, 2019 | 145 | 2019 |
| Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion Y Liu, B Jovanovic, M Pins, C Lee, RC Bergan Oncogene 21 (54), 8272-8281, 2002 | 141 | 2002 |
| MEK4 function, genistein treatment, and invasion of human prostate cancer cells L Xu, Y Ding, WJ Catalona, XJ Yang, WF Anderson, B Jovanovic, ... JNCI: Journal of the National Cancer Institute 101 (16), 1141-1155, 2009 | 137 | 2009 |
| Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3‐M cells S Mirzoeva, ND Kim, K Chiu, CA Franzen, RC Bergan, JC Pelling Molecular Carcinogenesis: Published in cooperation with the University of …, 2008 | 135 | 2008 |
| Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis JM Pavese, SN Krishna, RC Bergan The American journal of clinical nutrition 100, 431S-436S, 2014 | 129 | 2014 |
| A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer RC Bergan, E Reed, CE Myers, D Headlee, O Brawley, HK Cho, WD Figg, ... Clinical Cancer Research 5 (9), 2366-2373, 1999 | 123 | 1999 |
